It seems like it was only a few years ago that THC was the only cannabinoid anyone knew about. Then, with the advent of the CBD industry, the world was forced to face the fact that there’s a lot more to Cannabis sativa than a single intoxicating compound.
Since CBD entered the market, a variety of other cannabinoids have also started receiving attention from investors, producers, and consumers alike. Learn more about the emerging cannabinoids CBG, CBN, and CBC, and find out how bulk cannabinoid and white label producer GVB Biopharma is leading the hemp industry toward a more inclusive future.
Which cannabinoids are currently emerging into the market?
To a degree, it’s accurate to say that even CBD and THC are still emerging cannabinoids. Neither of these Cannabis sativa constituents have received comprehensive regulation or made their way entirely into the mainstream.
Much further into the fringe, however, you find practically unknown cannabinoids like CBG, CBN, and CBC. The hemp plant contains more than 100 unique cannabinoids, so these emerging cannabis constituents won’t be the last to enter the market. Right now, however, CBG, CBN, and CBC are the cannabinoids that are most clearly emerging into their own distinct market segments.
What is CBG?
Cannabigerol (CBG) is a cannabinoid that’s usually only found in Cannabis sativa in very small concentrations. Recently, however, breeders have started producing strains of hemp that contain CBG concentrations as high as 15-20%.
Since it’s just as easy to produce CBG-rich hemp as it is to produce CBD-rich hemp, industry experts expect CBG to become just as popular as CBD in the near future. While some of the benefits of CBG and CBD overlap, scientists have been keenly investigating the potential gastrointestinal and antimicrobial benefits of CBG.
What is CBN?
Cannabinol (CBN) naturally appears when THC oxidizes. In the early days of cannabis research, scientists thought that CBN, not THC, was the dominant cannabinoid in Cannabis sativa. This misunderstanding was quickly corrected, but CBN has remained a cannabinoid of considerable interest ever since.
Unlike THC, CBN is non-intoxicating, and consumers commonly use this cannabinoid to help sleep. Scientists have researched CBN for its potential neuroprotective properties, and CBN has also been investigated for its antimicrobial potential.
Using cutting-edge processes, it’s now possible to convert CBD into CBN extracts, making it much easier to produce this cannabinoid in mass quantities. So far, however, it’s proven impossible to breed strains of Cannabis sativa that are naturally high in CBN.
What is CBC?
One cannabinoid that’s still thoroughly in the “emerging” category is cannabichromene (CBC). At present, there are no Cannabis sativa strains that contain CBC in concentrations higher than 1%, making it hard to mass-produce this cannabinoid. Based on initial research, however, CBC appears to have unique benefits that will eventually launch this cannabinoid into widespread popularity.
For instance, CBC appears to have an even higher affinity than CBD for the nervous system’s TRPV1 receptors, which modulate inflammation. This cannabinoid has also been investigated for its ability to prevent the reuptake of anandamide, a body-generated cannabinoid (endocannabinoid) that’s involved in a variety of critical bodily processes.
Why are emerging cannabinoids important?
There’s only so much that CBD can do on its own. The more we learn, the clearer it becomes that the various components of the Cannabis sativa plant are designed to work together in synchrony.
Using selective breeding and other techniques, we can magnify the effects of specific cannabinoids, but it’s important to remember that every single cannabinoid has unique benefits to offer. Plus, expanding into new cannabinoids allows the hemp market to continue growing, benefiting every link of the supply chain.
Source your emerging cannabinoids from a reputable supplier
Emerging cannabinoids are fascinating and highly promising, but it’s important to source these new entrants to the hemp market from reputable, reliable suppliers like GVB Biopharma. As with any new industry, the CBG, CBN, and CBC industries are still relatively volatile, and disreputable suppliers might be more interested in making a quick profit than contributing to the future of hemp in a responsible way.
- Role of Cannabinoids in Gastrointestinal Mucosal Defense and Inflammation
- A systematic review of minor phytocannabinoids with promising neuroprotective potential
- Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice
Latest posts by HealthStatus Crew (see all)
- The Effectiveness Of The Hearing Aids - September 24, 2021
- A Brief Overview Of Chronic Obstructive Pulmonary Disease (COPD) and How To Treat It - September 24, 2021
- Is Health Insurance Worth Getting? - September 23, 2021